Navigation Links
Ampio Awarded US and Canadian Patents that will Bolster the Commercialization of Optina™ for the treatment of Diabetic Macular Edema (DME)
Date:4/27/2012

GREENWOOD VILLAGE, Colo., April 27, 2012 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (Nasdaq: AMPE), a biopharmaceutical company conducting clinical trials on its three lead drugs (Ampion™, Optina™ and Zertane™), licensing distribution of these drugs and developing additional new drugs, today announced that it received notice of allowance of a patent from the US office of patents and trademarks for its DME drug Optina™. Ampio also received a notice of allowance of a similar patent from the Canadian Intellectual Property Office. These initial patents cover the North American territories and multiple additional patents for using Optina™ for the treatment of macular edema and diabetic retinopathy are pending worldwide.

According to Michael Macaluso, Ampio's CEO, "Optina™ is an ultra-low oral (capsule), not commercially available, dose of danazol for the treatment of DME. To our knowledge, no other oral drug to treat this condition exists and there is currently no drug approved by the FDA for this condition. The allowance of these patents in North America is an important step in the development and commercialization of this novel drug as they include multiple claims for the beneficial effects of ultra-low dose Optina™ on vascular hyperpermeability encountered in DME and other vascular leakage syndromes. These patents have an unusually long patent life that expires in 2030. In contrast, most drugs at this stage of development (just before a pivotal trial) have exhausted a large portion of their patent life. These patent claims provide especially strong protection because of the unexpected finding of efficacy only at the very low doses. Ampio is currently in discussions with potential partners to co-develop Optina™ for DME."

Dr. David Bar-Or, Chief Scientific Officer for Ampio, explained, "The mode of action of Optin
'/>"/>

SOURCE Ampio Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Ampio Strengthens Patent Protection for Lead Drug Ampion™
2. Ampio Announces Positive Preliminary Update on the Optina™ Clinical Trial to Treat Diabetic Macular Edema and Decision to Conclude the Study Ahead of Schedule
3. Champions Oncology Reports Fiscal 2012 Third Quarter Financial Results
4. Ampio Pharmaceuticals Reports Full-Year 2011 Financial Results and Milestone Highlights for 2011
5. Ampio Pharmaceuticals Schedules 2012 Outlook Webcast
6. Executive Changes at Ampio
7. Ampio Pharmaceuticals Schedules Webcast to Update Shareholders
8. Ampio Pharmaceuticals Announces Registered Direct Common Stock Offering of Approximately $9.436 Million
9. Ampio Responds to Recent Publications by Anonymous Short Sellers
10. Champions Oncology Reports Fiscal 2012 Second Quarter Financial Results
11. FDA Advisory Panel Recommends Against Approval of Champion® Heart Failure Management System for Patients With Heart Failure
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... 2014   Acutus Medical, Inc. (ACM), ... 3D Cardiac Chamber Imaging and Dipole Density Mapping system ... sustain complex cardiac arrhythmias, including atrial fibrillation, announced it ... its imaging/mapping system as well as bring to market ... Medical to complete work on the AcQMap TM ...
(Date:9/30/2014)... PAUL, Minn. , Sept. 30, 2014 ... the United States abused prescription pain relievers ... include detoxification or maintenance treatment, which entails the use ... costs of these treatments are important when developing and ... by pharmacy benefit manager Prime Therapeutics LLC ...
(Date:9/30/2014)... Calif. , Sept. 30, 2014  Life ... group focused on supporting promising emerging biotech, medical ... been named the Top Angel Investment Group in ... as the best performer out of 370 angel ... historical performance, network strength (connections), selection aptitude and ...
Breaking Medicine Technology:Acutus Medical, Inc. Completes Additional $26.2M Series B Financing to Fund Portfolio Expansion 2Acutus Medical, Inc. Completes Additional $26.2M Series B Financing to Fund Portfolio Expansion 3Studies show cost and use of opioid dependence treatment are increasing, spurring the need for care management programs 2Studies show cost and use of opioid dependence treatment are increasing, spurring the need for care management programs 3Life Science Angels Ranked the Top Angel Investment Group in the U.S. 2Life Science Angels Ranked the Top Angel Investment Group in the U.S. 3
... FORT WASHINGTON, Pa., Nov. 13 ReSearch Pharmaceutical Services, ... integrated clinical development outsourcing solutions to the bio-pharmaceutical industry, ... quarter and nine months ended September 30, 2009. ... the quarter and nine months ended September 30, 2008. ...
... Calif., Nov. 13 Walt Maclay, President of ... been selected to speak on "Data Acquisition for ... 9, 2009. BIOMEDevice ( http://www.devicelink.com/expo/biomed09/index.html ) ... leaders in medical devices. The show offers a ...
Cached Medicine Technology:ReSearch Pharmaceutical Services, Inc. Unaudited Quarterly Report for the Period Ended September 30, 2009 2ReSearch Pharmaceutical Services, Inc. Unaudited Quarterly Report for the Period Ended September 30, 2009 3ReSearch Pharmaceutical Services, Inc. Unaudited Quarterly Report for the Period Ended September 30, 2009 4ReSearch Pharmaceutical Services, Inc. Unaudited Quarterly Report for the Period Ended September 30, 2009 5ReSearch Pharmaceutical Services, Inc. Unaudited Quarterly Report for the Period Ended September 30, 2009 6ReSearch Pharmaceutical Services, Inc. Unaudited Quarterly Report for the Period Ended September 30, 2009 7ReSearch Pharmaceutical Services, Inc. Unaudited Quarterly Report for the Period Ended September 30, 2009 8ReSearch Pharmaceutical Services, Inc. Unaudited Quarterly Report for the Period Ended September 30, 2009 9ReSearch Pharmaceutical Services, Inc. Unaudited Quarterly Report for the Period Ended September 30, 2009 10ReSearch Pharmaceutical Services, Inc. Unaudited Quarterly Report for the Period Ended September 30, 2009 11Voler Systems President Speaks at BIOMEDevice San Jose 2Voler Systems President Speaks at BIOMEDevice San Jose 3
(Date:10/1/2014)... Chicago IL (PRWEB) October 01, 2014 ... it has launched a new Other-Sonic Ultrasound ... public with information about the litigation surrounding the ... William Beaumont Hospital in Royal Oak, Michigan, which ... gel. The Firm is representing William Beaumont patients ...
(Date:10/1/2014)... Indosoft, Inc., a leading provider of scalable Asterisk-based ... added support for Sangoma Lyra Answering Machine Detection ... a history of bringing innovative products to market in the ... benefit to those using Asterisk as a platform for their ... of Q-Suite. , In the past decades, outbound call centers ...
(Date:10/1/2014)... 2014 The annual Social Security cost-of-living adjustment ... says a new forecast by The Senior Citizens League ... index (CPI) data through August, TSCL forecasts that COLAs will ... sixth consecutive year of record low COLAs,” states TSCL Chairman, ... automatic in 1975,” he notes. , Over the past five ...
(Date:10/1/2014)... October 01, 2014 QueenBeeTickets.com is giving music ... the singer’s upcoming North American tour, which has him traveling ... come. , Click here to view the selection ... performer’s newest album, is due to come out on October ... shortly thereafter. Bob Seger concert tickets are available for shows ...
(Date:9/30/2014)... same time could stop them from becoming resistant to ... Research * today (Wednesday). , The researchers, ... MedImmune, the global biologics research and development arm of ... two treatments helped the immune system hunt down and ... radiotherapy in mice with breast, skin and bowel cancers. ...
Breaking Medicine News(10 mins):Health News:Other-Sonic Ultrasound Gel Lawsuit Page Launched by The Oliver Law Group P.C. To Provide Information On Pseudomonas Outbreak Linked to Recalled Ultrasound Gel 2Health News:Other-Sonic Ultrasound Gel Lawsuit Page Launched by The Oliver Law Group P.C. To Provide Information On Pseudomonas Outbreak Linked to Recalled Ultrasound Gel 3Health News:Other-Sonic Ultrasound Gel Lawsuit Page Launched by The Oliver Law Group P.C. To Provide Information On Pseudomonas Outbreak Linked to Recalled Ultrasound Gel 4Health News:Indosoft Announces Q-Suite Support For Sangoma Lyra 2Health News:The Senior Citizens League (TSCL) Says Sixth Consecutive Year Of Record Low COLAs “Unprecedented” 2Health News:The Senior Citizens League (TSCL) Says Sixth Consecutive Year Of Record Low COLAs “Unprecedented” 3Health News:Bob Seger Presale Tickets: QueenBeeTickets.com Delights Fans with Discounted Tickets for All 20 Stops on Seger’s “Ride Out” Tour with The Silver Bullet Band 2Health News:Immunotherapy could stop resistance to radiotherapy 2
... Kaiser ... medical surge facility at the 2010 Pasadena Marathon in California. , ... Pasadena, CA (Vocus) March 17, 2010 -- Kaiser ... DRASH medical surge facility at the 2010 Pasadena Marathon in California., , , ...
... million more Americans access to health insurance , ... year of fierce partisan debate, the Democrat-controlled House ... $940 billion health-care reform bill, which would extend ... prevent insurance companies from denying coverage to people ...
... the genomes of thousands of "never smokers" diagnosed with lung cancer ... say could be responsible for a significant number of those cancers. ... Lancet Oncology , the researchers reported that about 30 percent ... the same uncommon variant, or allele, residing in a gene known ...
... organization Eagle Forum, made the following remarks after the public announcement that formerly pro-life Democrat Bart Stupak (D-MI) will cast a "yes" vote for the Senate ... ... ... ...
... more Americans access to health insurance , FRIDAY, March ... furiously debated $940 billion health-care reform bill moving toward ... boils down to one simple tenet: More Americans should ... is the coverage of 31 million uninsured individuals, and ...
... 21 Family Research Council President Tony Perkins released the following statement in response to reports that President Obama may issue an executive order regarding government funding of ... ... ... ...
Cached Medicine News:Health News:DRASH Keeps Marathon Runners On Track 2Health News:DRASH Keeps Marathon Runners On Track 3Health News:House Democrats Approve Health-Care Reform Bill 2Health News:House Democrats Approve Health-Care Reform Bill 3Health News:House Democrats Approve Health-Care Reform Bill 4Health News:Gene is linked to lung cancer development in never-smokers 2Health News:Gene is linked to lung cancer development in never-smokers 3Health News:Gene is linked to lung cancer development in never-smokers 4Health News:Schlafly: Health Care Vote Set to Expose the Myth of the 'Pro-Life Democrat' 2Health News:Schlafly: Health Care Vote Set to Expose the Myth of the 'Pro-Life Democrat' 3Health News:Showdown Over Health-Care Reform Bill Nears 2Health News:Showdown Over Health-Care Reform Bill Nears 3Health News:Showdown Over Health-Care Reform Bill Nears 4Health News:Executive Order Will In No Way Prevent Federal Funding of Elective Abortion 2Health News:Executive Order Will In No Way Prevent Federal Funding of Elective Abortion 3Health News:Executive Order Will In No Way Prevent Federal Funding of Elective Abortion 4
... in two tip styles- the ... staggered eyes, and the angled ... catheter valve options, SAFE-T-VAC and ... with virtually no residual vacuum ...
Sterile Single Loop Pediatric Suction Catheters with TOUCH-TROL Valve...
... Our Tri-Flo® suction catheter design ... to your patients while still providing ... pediatric catheters (5/6, 8 or 10 ... facilitate proper catheter placement. Our complete ...
Suction catheter with thumb valve, two eyes, whistle tip...
Medicine Products: